Deerfield wins fight to acquire Singular Genomics, beating out Tang Capital’s Concentra

An affiliate of Deerfield Management Company will acquire Singular Genomics Systems, ending a months-long competition between two suitors that bid up the price of the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

The state pharma’s targeting this election cycle

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in

July 25, 2024

What Caused Boy in Rural Area to Develop High Fever and Hemoptysis?

What to do for this 7-year-old boy who was admitted to hospital 1 week after developing a fever that reached temperatures up to 40.2°C (104.4°F)?

July 18, 2023

Astellas Acquires Eye-Disease Specialist Iveric for Almost $6B

Credit: FG Trade/Getty Images Astellas is acquiring Iveric Bio for approximately $5.9 billion, making Iveric a wholly-owned subsidiary. The purchase price, $40.00 per share, represents

May 1, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.